What GLP-1 does FEP Blue cover? For weight loss, Standard and Basic cover Wegovy and Saxenda at Tier 3, and all three options cover generic liraglutide at Tier 1, with prior approval. Focus needs an exception for Wegovy, and every option needs one for Zepbound. Ozempic, Mounjaro, Rybelsus, and Trulicity are covered for type 2 diabetes, with prior approval. Drug lists · Exception rules
Affiliate disclosure: We may earn a commission if you use some links on this page, like Ro or Sesame. That never changes what FEP covers or the numbers we show. And you never need a paid service to check your FEP benefits.
Covered doesn't mean cheap, though. At a Preferred retail pharmacy, Wegovy's usual Tier 3 cost share is 50% of FEP's price on Standard and 60% on Basic. Standard's brochure lists a mail-order Tier 3 cap of $250 per eligible fill—but that is not a confirmed Wegovy quote or a promise that Mail Service can fill it. Check that mail option before paying cash or buying a new membership. Below, we'll show you what to compare on your option, and exactly what FEP needs before it says yes. 2026 benefit rules, Section 5(f)
This page is for you if your card says FEP Blue Standard, Basic, or Focus. That includes FEHB (the Federal Employees Health Benefits program) and PSHB (the Postal Service Health Benefits program). The main cost tables use traditional FEHB benefits without Medicare adjustments. Here, traditional means FEP's regular drug coverage, not MPDP. Postal and Medicare members have a separate section below. You'll learn which GLP-1 your option lists, how to get your real price, and what approval requires.
It's not for you if:
- Your card says a state Blue Cross plan, like Anthem or Blue Cross Blue Shield of Texas. Your drug list is different. Go to what GLP-1 Blue Cross plans cover.
- You're on another federal plan, like GEHA. See how FEHB plans cover GLP-1s.
- You're in FEP's Medicare drug plan (MPDP). It uses its own list. Jump to the Medicare section.
- You want a compounded GLP-1. This page covers FDA-approved products, not compounded substitutes. Compounded drugs are not FDA-approved. To compare those separate treatment paths, use The RX Index's Find My GLP-1 Path tool. FDA explanation
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
FEP Blue GLP-1 coverage at a glance (2026)
| GLP-1 (what it's for) | FEP Blue Standard | FEP Blue Basic | FEP Blue Focus |
|---|---|---|---|
| Wegovy single-dose pen, pill, or HD 7.2 mg (weight) | Tier 3 + prior approval | Tier 3 + prior approval | Exception only; Tier 2 if approved |
| Saxenda (weight) | Tier 3 + prior approval | Tier 3 + prior approval | Not on the list |
| Generic liraglutide for weight management | Tier 1 + prior approval | Tier 1 + prior approval | Tier 1 + prior approval |
| Zepbound (weight) | Exception only; Tier 3 if approved | Exception only; Tier 3 if approved | Exception only; Tier 2 if approved |
| Ozempic, Mounjaro, Rybelsus, Trulicity (type 2 diabetes) | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval |
| Foundayo (weight) | Not found in the reviewed list | Not found in the reviewed list | Not found in the reviewed list |
Sources: full Standard, Basic, and Focus formularies and FEP's pharmacy FAQ. Public sources checked September 22, 2026. Listings are for the named products, not every presentation of the same medicine. The drug, diagnosis, and benefit must all match your request.
See what it costs on your plan ↓
What we actually verified
| We checked | We did not check |
|---|---|
| FEP's 2026 drug lists for Standard, Basic, and Focus | Your own FEP account or claims |
| FEP's prior-approval policies for Wegovy and Saxenda (5.99.030), Zepbound (5.99.031), and diabetes GLP-1s (5.30.086) | A real prior approval request |
| FEP's Zepbound request form, preferred-drug list, and published prior-approval updates | Whether your pharmacy has your drug in stock |
| FEP's 2026 brochures, cost rules, and premiums | A price quote from FEP's Mail Service Pharmacy |
| OPM's 2027 carrier letters and official Open Season information | A final 2027 FEP price for your prescription |
| Current manufacturer offers and Ro's and Sesame's public program terms | A full Ro or Sesame signup, claim, or cancellation |
We did the comparison math ourselves from the published rules and prices. Calculations below are labeled; they are not patient quotes. FEP and CVS Caremark have the final word on your coverage. See how we checked ↓
On this page: Drug list · Costs · Which one to ask for · The catch · Wegovy rules · Getting approved · Zepbound · Focus · Diabetes · PSHB and Medicare · 2027 · Denied? · How we checked · FAQ
What GLP-1 does FEP Blue cover on Standard, Basic, and Focus?
FEP Blue covers GLP-1s in two lanes: weight management and type 2 diabetes. For weight loss, Standard and Basic list Wegovy and Saxenda at Tier 3 and generic liraglutide at Tier 1, while Focus lists only generic liraglutide. Zepbound needs a formulary exception on every option, and each listed GLP-1 below needs prior approval. Official lists · FEP exception rules
We built these two tables from FEP's three 2026 drug lists, its GLP-1 prior-approval policies, and its pharmacy FAQ. The "FEP limit" column shows the quantity listed in the relevant policy—not a promise that every pharmacy will dispense that much at once.
Weight-management GLP-1s
| Drug | Standard | Basic | Focus | Published FEP limit | Weight-management approval lasts |
|---|---|---|---|---|---|
| Wegovy single-dose pen, including adult HD 7.2 mg | Tier 3 + prior approval | Tier 3 + prior approval | Exception; Tier 2 if approved | 12 single-dose pens per 84 days | 6 months, then 12 |
| Wegovy pill (adults 18+) | Tier 3 + prior approval | Tier 3 + prior approval | Exception; Tier 2 if approved | 90 tablets per 90 days | 6 months, then 12 |
| Saxenda (brand) | Tier 3 + prior approval | Tier 3 + prior approval | Not on the list | 15 pens per 90 days | 6 months, then 12 |
| Generic liraglutide for weight management (Saxenda's generic) | Tier 1 + prior approval | Tier 1 + prior approval | Tier 1 + prior approval | Saxenda/liraglutide policy: 15 pens per 90 days | 6 months, then 12 |
| Zepbound single-dose pen (adults 18+) | Excluded list; exception, then Tier 3 | Managed Not Covered list; exception, then Tier 3 | Not on the list; exception, then Tier 2 | 12 single-dose pens per 84 days | 6 months, then 12 |
| Foundayo pill | Not found in reviewed list | Not found in reviewed list | Not found in reviewed list | No limit verified | No approval period verified |
Type 2 diabetes GLP-1s
| Drug | Standard | Basic | Focus | Published FEP limit | Approval lasts |
|---|---|---|---|---|---|
| Ozempic pens | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval | 3 pens per 84 days | 12 months |
| Ozempic tablets (1.5, 4, 9 mg) | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval | 90 tablets per 90 days | 12 months |
| Rybelsus | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval | 90 tablets per 90 days | 12 months |
| Mounjaro single-dose pens | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval | 12 pens per 84 days | 12 months |
| Trulicity | Tier 2 + prior approval | Tier 2 + prior approval | Tier 2 + prior approval | 12 pens per 84 days | 12 months |
| Generic liraglutide for diabetes (Victoza's generic) | Tier 1 + prior approval | Tier 1 + prior approval | Tier 1 + prior approval | Confirm the exact generic product with FEP | 12 months under the diabetes policy |
| Victoza (brand) | Tier 3 + prior approval | Tier 3 + prior approval | Not on the list | 9 pens per 90 days | 12 months |
Sources: full Standard, Basic, and Focus lists; policies 5.99.030, 5.99.031, and 5.30.086; Saxenda/liraglutide brand-or-generic request form; FEP pharmacy FAQ. Checked September 22, 2026. The six-month first approval is for weight management; Wegovy's separate MASH criteria use 12 months.
One name is not enough. Ask for the exact product, strength, and form. Generic liraglutide for diabetes and generic liraglutide for weight management are separate coverage checks. The single-dose pen limits above do not establish coverage or quantities for a multi-dose pen, vial, or syringe. FEP policies and product lists
"Covered" really means four different yeses
When someone says FEP "covers" a GLP-1, they're usually mixing up four separate questions:
- Is it on my option's list? That's the tables above.
- Will FEP approve it for me? That's prior approval. FEP has to say yes before it pays.
- What will I pay? Your benefit, tier, pharmacy, and the price FEP uses decide that.
- Can my pharmacy fill it? Approval doesn't mean it's in stock.
A lot of the mixed answers online come from treating these as one question. This page separates all four and gives you the questions to finish your own check.
Tier, prior approval, exception: the 30-second decoder
- Formulary: FEP's list of covered drugs. Standard, Basic, and Focus each have their own.
- Tier: the cost-sharing category on that list. Tier 1 is generics, Tier 2 is preferred brands, and Tier 3 is non-preferred brands. Standard and Basic also have specialty Tiers 4 and 5. Focus has only Tiers 1 and 2. FEP's tier definitions
- Prior approval: FEP's name for prior authorization. Your prescriber sends proof that you meet FEP's rules, and FEP has to say yes before it pays.
- Formulary exception: a request to cover a drug that isn't on your option's list. Your prescriber explains why the listed drugs won't work for you.
- Excluded and Managed Not Covered lists: drugs FEP won't cover unless an exception is approved. Standard has an Excluded list. Basic has a Managed Not Covered list.
Want the longer version? See how GLP-1 formulary tiers work.
Is Foundayo covered by FEP Blue?
We did not find Foundayo in the full Standard, Basic, or Focus lists reviewed on September 22, 2026, or in the GLP-1 approval policies and update log we checked. That is not the same as a written denial for your plan. Ask FEP to check Foundayo by name and send the current coverage or exception rule. Drug lists · Policy updates
Foundayo (orforglipron) is an FDA-approved daily GLP-1 pill for eligible adults with obesity or overweight and a weight-related condition. FDA approval does not put it on FEP's formulary. For a weight-management pill that is listed today, the Wegovy pill is Tier 3 on Standard and Basic. FDA approval · Standard list · Basic list
Does FEP cover older weight-loss pills?
FEP's policies name older weight-loss medicines, including phentermine, Qsymia, and Contrave. But a drug appearing in a policy is not proof of coverage on your option. Check its formulary entry and approval rules. For Zepbound, the weight-management criteria require inadequate response, intolerance, or a medical reason not to use at least two oral weight-loss drugs. More on that in the Zepbound section. Zepbound criteria
The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to explore provider options before you choose. Confirm the exact drug price with FEP or the dispensing pharmacy before paying.
How much will a GLP-1 cost me with FEP Blue?
What you pay for a GLP-1 on FEP Blue depends on your option, the drug's tier, and where you fill it. At a Preferred retail pharmacy, ordinary Tier 3 drugs like Wegovy cost 50% of FEP's price on Standard and 60% on Basic, without a per-fill dollar cap. Standard's brochure lists a $250 cap for an eligible Tier 3 mail fill of more than 21 days and up to 90 days. Section 5(f)
Here are FEP's 2026 cost rules. A percent means a percent of FEP's price for the drug (FEP calls it the "Plan allowance"). A copay is a flat dollar amount.
FEP Blue pharmacy cost rules (2026)
Traditional FEHB benefits; Preferred pharmacies; no Medicare adjustments. These are the ordinary drug-tier rules. The separate preferred-diabetes benefit is explained below.
| Option and pharmacy | Tier 1 (generics) | Tier 2 (preferred brands) | Tier 3 (non-preferred brands) |
|---|---|---|---|
| Standard, regular pharmacy | $7.50 up to 30 days; $22.50 for 31 to 90 days | 30% | 50%; no per-fill cap |
| Standard, mail order, more than 21 days and up to 90 days | $15 | 15%, up to $150 | 20%, up to $250 |
| Basic, regular pharmacy | $15 up to 30 days; $40 for 31 to 90 days | 35%, up to $150 for 30 days or $400 for 31 to 90 days | 60%; no per-fill cap |
| Basic, mail order | Only with Medicare Part B primary under this traditional FEHB benefit | See Medicare section | See Medicare section |
| Focus, regular pharmacy | $5 up to 30 days; $15 for 31 to 90 days | 40%, up to $500 for 30 days or $1,300 for up to 90 days | Focus has no Tier 3 |
| Focus, mail order | Not offered | Not offered | Not offered |
Sources: FEP 2026 Standard and Basic brochure, Section 5(f), and FEP Blue Focus 2026 brochure. "Regular pharmacy" means a Preferred retail pharmacy. These prescription benefits do not have a deductible. Checked September 22, 2026. Mail availability, approved quantity, and special drug benefits still need an exact-product check.
What Wegovy really costs on each option
There is no verified $675 Standard or $809 Basic price for your box. Those numbers come from multiplying Wegovy's list price by 50% or 60%. FEP bills from its Plan allowance, not automatically from the manufacturer's list price. Use the pharmacy quote—not the list-price shortcut. FEP benefit rules
| Where you fill it | What determines your actual drug cost | The next question that matters |
|---|---|---|
| Standard, regular pharmacy | 50% of FEP's allowance, subject to your remaining annual protection and any eligible savings | "What is my approved claim price at this pharmacy?" |
| Standard, mail order | Section 5(f) lists 20%, capped at $250, for an eligible fill of more than 21 days and up to 90 days | "Can you fill my exact Wegovy prescription, and does this cap apply to it?" |
| Basic, regular pharmacy | 60% of FEP's allowance, subject to your remaining annual protection and any eligible savings | "What is my final cost compared with the cash offer for the same supply?" |
| Focus, after an approved exception | 40% of FEP's allowance, capped at $500 for up to 30 days or $1,300 for up to 90 days | "Which quantity is approved, and what is my price after the exception?" |
| Eligible cash purchase, Wegovy single-dose pens through 2.4 mg | $349 for four pens, a 28-day supply, under Novo's current offer | "Do I qualify, and is there a separate visit or membership fee?" |
Sources: Standard/Basic brochure, Focus brochure, and NovoCare prices and terms. These are coverage rules and advertised offers, not a processed member claim.
Your yearly limit may kick in first. For traditional FEHB Preferred care, the 2026 Self Only out-of-pocket limits are $6,000 on Standard, $7,500 on Basic, and $10,000 on Focus. Eligible covered prescription cost sharing counts toward that protection. Premiums, noncovered charges, and other excluded expenses do not. That is why multiplying a high monthly copay by 13 is not a reliable yearly bill. Standard/Basic catastrophic protection · Focus catastrophic protection
For your yearly budget, record the approved cost per fill, days supplied, remaining out-of-pocket limit, premiums, and any separate care fee. Thirteen 28-day boxes cover 364 days; twelve 30-day tablet fills cover 360 days. Compare the same length of treatment.
The mail-order cap: what Standard members should check first
On Standard, Section 5(f) lists a mail-order fill of more than 21 days and up to 90 days at 20% of FEP's price, but never more than $250 for Tier 3. The same section says not all drugs are available through Mail Service. A quantity limit of 12 Wegovy single-dose pens per 84 days does not prove that Mail Service can supply your prescription. Brochure · Wegovy quantity policy
Here's the useful math—not a pharmacy quote: if Mail Service confirms an eligible 84-day fill at the $250 cap, that is $20.83 per week. Three $349 cash boxes cover the same 84 days for $1,047. The difference is $797 in drug cost over 12 weeks, before any separate clinical fees or eligible savings-card help.
How to check it:
- Call Mail Service at 1-800-262-7890 with the exact drug, form, strength, and proposed days' supply. Ask whether it can be filled and what you would pay after approval.
- If that price works, ask your prescriber whether that supply is right for your treatment and to send the prescription. Do not order extra starting-dose medicine just to reach a mail-order quantity.
Heads up: FEP's own documents don't all agree on mail prices. Section 5(f) lists Standard Tier 3 mail order at 20%, up to $250. The summary near the end of the same brochure instead shows a $125 non-preferred-brand mail copay. We have not resolved that mismatch with FEP or obtained a Wegovy quote. Before you switch, call Mail Service and ask: "What will an 84-day fill of my drug cost me on Standard, and which benefit rule applies?" Section 5(f), printed page 104, and summary, printed page 163
When is paying cash cheaper than using FEP Blue?
Cash is cheaper for that fill when the eligible cash price plus any extra care fee is below your final insurance price for the same supply. It does not automatically win on every FEP option. Your actual allowance, savings offer, and remaining yearly out-of-pocket limit can change the answer.
Current Wegovy cash offers, checked September 22, 2026:
| Exact product | Advertised drug-only price | Supply | The catch |
|---|---|---|---|
| Wegovy single-dose pens, 0.25–2.4 mg | $349 | Four pens / 28 days | Eligibility and prescription required; care fees are separate |
| Qualifying first two Wegovy starter-dose fills, 0.25 or 0.5 mg | $199 each | Four pens / 28 days per fill | Each qualifying fill must be redeemed by December 31, 2026; signing up by then is not enough |
| Wegovy HD 7.2 mg | $399 | Four pens / 28 days | Not part of the $349 pen price or starter offer |
| Wegovy 1.5 mg tablets | $149 | 30 tablets / 30 days | Starting dose, not a $149 long-term maintenance promise |
| Wegovy 4 mg tablets | $199 | 30 tablets / 30 days | Dose-escalation price |
| Wegovy 9 mg or 25 mg tablets | $299 | 30 tablets / 30 days | Your clinician chooses the dose; 25 mg is the labeled tablet maintenance dose |
Sources: NovoCare, full savings-offer terms, and Wegovy prescribing information. Ro lists the same drug prices on its pricing page, with a separate membership charge.
The $199 starter offer has a new-patient rule: Novo defines new patients as those who have not used a prior Wegovy savings offer in the past 365 days. Both qualifying fills must meet the December 31, 2026 deadline. Full terms
When would FEP beat the $349 pen cash price at a regular pharmacy? Here is our break-even calculation, before coupons, separate care fees, or annual out-of-pocket protection:
| Traditional FEHB option | Calculation | FEP allowance below which the ordinary retail share is less than $349 |
|---|---|---|
| Standard, Tier 3 | $349 ÷ 50% | $698 per matching 28-day box |
| Basic, Tier 3 | $349 ÷ 60% | $581.67 per matching 28-day box |
| Focus, approved Tier 2 exception | $349 ÷ 40% | $872.50 per matching 28-day box |
These are thresholds, not estimates of FEP's negotiated price. The Focus cap does not affect this particular calculation because $349 is below its $500 cap. Use the same method with your prescribed tablet or HD price rather than mixing products.
Two catches with the manufacturer cash offer: you still need a prescription, and those purchases cannot be submitted to insurance for reimbursement or applied to your deductible or out-of-pocket limit under the offer's terms. Novo's terms
Our tip: before you pay for any new program, get two numbers. First, your FEP price after approval. Second, the cash price. Add any separate visit or membership charge, and check what counts toward your yearly limit. Then choose the lower total cost for the treatment your clinician recommends.
Can I use the Wegovy savings card with FEP Blue?
Eligible FEHB members can: Novo's terms do not classify FEHB as government insurance for the commercial savings offer. You also need an FDA-approved use and must meet the remaining terms, including restrictions on copay-accumulator, maximizer, or alternate-funding arrangements. The commercial offer cannot be used with MPDP or other excluded Medicare prescription coverage. PSHB members should confirm eligibility rather than assume the FEHB wording covers them. Offer eligibility
The current maximum saving is $100 for one qualifying month's supply, $200 for two, or $300 for three. So a hypothetical $675 covered cost would fall to $575 with the full $100 saving—not to $25. That example is arithmetic, not an FEP quote. Compare the final price with the cash offer and ask whether your pharmacy accepts the card for that fill. Savings limits
We couldn't confirm how FEP counts the card's savings toward your yearly costs, so ask CVS Caremark before you count on it. The terms change, so read the current ones first. More in our Wegovy savings card guide.
Why is Wegovy so expensive on FEP Blue now?
FEP says it plainly. Its pharmacy FAQ identifies rising use of weight-loss GLP-1s as a main driver of costs and explains why these medicines have higher member cost sharing. That explains the plan's position; it does not establish the price of your next fill. FEP's explanation
What diabetes GLP-1s and generic liraglutide cost
Generic liraglutide is Tier 1 on all three traditional lists. For a covered Preferred-retail fill of up to 30 days, the ordinary generic copay is $7.50 on Standard, $15 on Basic, or $5 on Focus. A longer supply has different copays, shown above. Drug lists · Standard/Basic costs · Focus costs
For diabetes brands, ask one extra question: "Does this exact prescription use the ordinary Tier 2 benefit or the separate preferred-diabetes benefit?" FEP publishes both. A Tier 2 listing alone does not answer that pricing question.
| Published traditional FEHB benefit category | Standard, Preferred retail | Basic, Preferred retail | Standard, eligible mail order |
|---|---|---|---|
| Ordinary Tier 2 preferred brands | 30% | 35%, up to $150 for 30 days or $400 for 31–90 days | 15%, up to $150 |
| Other Preferred Diabetic Medications, when that specific benefit applies | 20% | $35 for up to 30 days; $65 for 31–90 days | $40 for up to 90 days |
Source: Section 5(f), including "Other Preferred Diabetic Medications, Test Strips and Supplies," printed pages 102–106. The brochure does not identify each GLP-1 in that special-benefit table. We did not verify which row a particular member's Ozempic, Mounjaro, Rybelsus, or Trulicity claim uses. Medicare-adjusted Basic benefits differ.
Do not budget from an Ozempic list-price calculation when a drug-specific benefit or cap may apply. Get the exact-product quote first.
Get your exact price in FEP's drug cost tool → Search the exact product under your plan and pick your pharmacy. Rather call? FEP's Retail Pharmacy Program is 1-800-624-5060. Official pharmacy resources
Your FEP price-check card: copy or print this
| Write this down | Your answer |
|---|---|
| FEHB or PSHB; Standard, Basic, or Focus; traditional benefit or MPDP | __________ |
| Drug, form, strength, and days supplied | __________ |
| Prior approval, exception, or both; approval expiration date | __________ |
| Preferred retail price after approval and any eligible savings | $__________ |
| Mail Service: available for this prescription? Confirmed price and days supplied? | __________ |
| Eligible cash price for the same product and supply | $__________ |
| Extra visit or membership fee | $__________ |
| What counts toward my yearly out-of-pocket limit? How much remains? | __________ |
| Quote date, representative, and reference number | __________ |
You don't need a new subscription to complete this card. Start with your plan and your pharmacy.
Which GLP-1 should I ask my doctor about on my FEP plan?
On FEP Blue Standard or Basic, Wegovy and Saxenda are listed weight-management options with prior approval; Zepbound needs an exception. Generic liraglutide has the lowest ordinary retail tier cost of the listed weight-management GLP-1s on all three options. If you have type 2 diabetes, Ozempic, Mounjaro, Rybelsus, and Trulicity are Tier 2. FEP lists · Exception rules
Your prescriber decides what's medically right for you. This table is only about what FEP covers and what it costs.
| If you... | Ask your prescriber about | Why it fits FEP's rules | Watch out for |
|---|---|---|---|
| Have Standard and want weight-loss coverage | Listed Wegovy, Saxenda, or generic liraglutide; compare eligible mail service | Listed options avoid a non-formulary exception | A mail benefit is not proof that your drug can be mailed |
| Have Basic | Wegovy, Saxenda, or generic liraglutide | Generic liraglutide is Tier 1; Wegovy and Saxenda are Tier 3 | Compare the actual covered Wegovy price with the cash offer and any extra care fee |
| Have Focus | Generic liraglutide; an exception for a non-formulary option when medically needed | Weight-management liraglutide is Tier 1 | No mail order; Wegovy and Zepbound need exception review |
| Have type 2 diabetes | Ozempic, Mounjaro, Rybelsus, Trulicity, or generic liraglutide | A separate diabetes policy; no metformin trial in its current criteria | Initial diagnostic records and renewal records are different |
| Want Zepbound | Your option's exception requirements, or eligible cash pricing | Standard/Basic and Focus have different branches on the request form | Prior use or samples don't guarantee approval |
| Want a weight-management pill | The Wegovy pill | Tier 3 on Standard and Basic, adults 18+ | Foundayo was not found in reviewed lists; Ro's insurance help is limited to selected pens |
| Are 12 to 17, or a parent | Age-appropriate Wegovy injections or Saxenda | FEP has pediatric criteria from age 12 | Not Wegovy HD or tablets; Saxenda's label also requires weight above 60 kg |
| Are in MPDP | Your MPDP drug list first | Different list, different rules | See the Medicare section |
| Want the lowest ordinary covered retail cost | Generic liraglutide for the intended use | Tier 1: $5–$15 for up to 30 days, depending on option | It's a daily shot, not weekly; price does not decide medical fit |
Sources: formularies, Wegovy/Saxenda criteria, Zepbound form, diabetes criteria, Wegovy label, and Saxenda label.
Coverage is not medical clearance. Your clinician needs to review your history and other medicines. Wegovy, Saxenda, and Zepbound have boxed warnings and must not be used with a personal or family history of medullary thyroid carcinoma or MEN 2. These medicines can also have serious side effects; read the Wegovy, Saxenda, or Zepbound safety information for the drug prescribed. Do not combine GLP-1 medicines or change doses to chase a lower price.
Plan-by-plan prescriber lists: Standard · Basic · Focus
What's the catch with FEP Blue GLP-1 coverage?
FEP Blue's first weight-management approvals for Wegovy, Saxenda, and Zepbound last 6 months, and the policies require a weight program at the start and renewal. The adult renewal rule is at least 5% loss from baseline or keeping that initial loss off. Pediatric renewals and Wegovy's MASH treatment use different rules. Wegovy/Saxenda criteria · Zepbound criteria
| The catch | What it means for you | What to do |
|---|---|---|
| First weight-management approval lasts 6 months | You need renewal before that approval expires | Set a calendar reminder the day you're approved; ask about renewal around month 5 |
| A program is required at start and renewal for weight management | The request needs the required program information | Check eligibility for FEP's free program or use another qualifying program; keep records |
| The adult 5% rule at renewal | Less than the required response can affect continued coverage | Write down your starting weight and the date; use the correct adult or pediatric rule |
| Ordinary Tier 3 retail cost has no per-fill cap | A covered prescription can still have a large bill | Compare your processed price with eligible mail service and cash; include yearly protection |
| No GLP-1 tier exceptions | Approval of a non-formulary drug does not earn a lower tier | Plan around the tier's cost |
| Zepbound has extra steps | Standard/Basic list two preferred products plus the two-oral-drug criterion | Use the Zepbound checklist; Focus members need their own form branch |
| Focus is a closed list | Unlisted drugs need an approved exception | Check generic liraglutide's exact entry before paying for exception-only care |
| Basic mail eligibility is limited | Traditional FEHB Basic needs Medicare Part B primary | Do not assume Standard's mail rule applies to Basic or to PSHB |
| 2027 has additional program requirements | OPM calls for documented participation, not just a signed statement | Keep participation records; verify FEP's final 2027 requirements |
Sources: FEP FAQ, 2026 benefit rules, Focus brochure, Zepbound form, and OPM's 2027 carrier letter.
What does FEP Blue require to approve Wegovy or Saxenda?
For adult weight management, FEP's Wegovy and Saxenda rules (policy 5.99.030) require a BMI of 30 or more, or 27 or more with a qualifying condition such as established heart disease, type 2 diabetes, high cholesterol, or high blood pressure. You also need a weight management program and no second GLP-1. First weight-management approvals last 6 months; adult renewals last 12 months when the response and other criteria are met. Full policy
The Wegovy and Saxenda checklist (printable)
- [ ] Age and product: age 12 or older for the pediatric Wegovy injection or Saxenda path; age 18 or older for Wegovy tablets or HD 7.2 mg. Use the separate teen criteria below.
- [ ] A recent visit note with your height, weight, BMI, and the date
- [ ] Adult BMI of 27 to 29.9? A note showing a qualifying weight-related condition
- [ ] Proof you're in a weight management program
- [ ] No doubling up: not on another GLP-1, or another weight-loss drug that needs prior approval, at the same time
- [ ] Your starting weight, written down with the date. You'll need it at renewal.
- [ ] A calendar reminder for month 5, based on the actual approval letter
Your prescriber needs to send records, not just a note that says you meet the rules. See which documents to gather for a GLP-1 prior approval.
What weight program does FEP Blue accept?
FEP's policy asks for a comprehensive weight management program and names Teladoc as one example, alongside other programs. The easy button: FEP offers the Teladoc Health Weight Management Program at no cost to eligible members. You get a smart scale, coaching, and feedback from dietitians. Take screenshots of your sign-up and your activity. Your prescriber may need them. FEP's program · Approval criteria
Check eligibility before you count on it. FEP's program page says age 13 or older, with an eligible adult BMI claim or pediatric percentile claim within the last three years. For adults, it lists a BMI of 25 or higher; for pediatric members, the 85th percentile or higher. That program's age floor is not the same as the drug policy's age-12 floor. A 12-year-old needs another acceptable program arranged with the clinician. Program eligibility
How FEP Blue renewals work (the 6-month clock)
| When | What happens for adult weight-management coverage |
|---|---|
| Month 0 | FEP approves the initial request for 6 months |
| Around month 5 | Ask your prescriber when to submit renewal with current weight, starting weight, and program records |
| End date on your letter | Your first approval expires |
| Renewal | Up to 12 more months if you've lost at least 5% of baseline weight, or maintained the initial qualifying loss, and meet the other criteria |
| Later renewals | Recheck the current policy and the next expiration date |
Source: FEP's weight-management renewal criteria. Month 5 is our planning reminder, not a guaranteed FEP filing window.
Saying "the medicine is working" isn't enough. FEP wants your starting weight and your current weight in the records. More on first requests vs. renewals.
Can teens get Wegovy or Saxenda on FEP Blue?
Yes, FEP has weight-management criteria from age 12 for Wegovy injections and Saxenda: BMI at or above the 95th percentile for age and sex, plus the other policy requirements. Saxenda's FDA label also requires body weight above 60 kg, about 132 pounds. The Wegovy pill, Wegovy HD 7.2 mg, and Zepbound are adult options. FEP criteria · Wegovy label · Saxenda label · Zepbound label
The teen renewal rule is not the adult 5% rule. FEP asks for clinically significant weight loss under its pediatric criteria. Have the child's clinician document the response using that section, not the adult checklist. Pediatric renewal criteria
Does FEP Blue cover Wegovy for fatty liver disease (MASH)?
FEP publishes a separate Wegovy injection approval path for adults with noncirrhotic MASH and moderate to advanced liver scarring, stage F2 to F3. MASH is fatty liver disease with inflammation. The request needs a qualifying liver biopsy within 6 months or specified imaging within 3 months, plus specialist involvement and the rest of the policy's criteria. It is not a general approval for any fatty liver diagnosis. Initial approvals and renewals are 12 months. MASH criteria
The biopsy path requires a liver activity score, called NAS, of at least 4—or, with a lower score, both liver-cell ballooning and fat buildup. The imaging options named are elastography, CT, or MRI, supporting F2–F3 disease. The prescriber must be an endocrinologist, gastroenterologist, or hepatologist, or work with one. Your specialist should send the actual report. FEP MASH criteria FEP also requires management of related conditions and use with diet and exercise. Its exclusions include cirrhosis, specified significant alcohol use, liver cancer, and listed other chronic liver diseases. Renewal asks for at least one stage of fibrosis improvement within a year, or no worsening after two or more years of therapy, along with the other criteria. The FDA-approved MASH treatment is the Wegovy injection—not the pill or the adult 7.2 mg weight-loss dose. FEP policy · Wegovy label
Does FEP Blue cover Wegovy for heart health?
Wegovy has an FDA-approved use to reduce major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. But FEP's published policy reviewed here does not set out a separate cardiovascular-only approval section. Established heart disease is one of the conditions that can meet its adult weight-management path at BMI 27 or more. FDA-approved labeling · FEP criteria
That gap is not proof that FEP automatically denies every heart-risk request. Ask which criteria apply to your exact benefit and diagnosis; MPDP uses a separate review. Have your clinician include the documented cardiovascular disease rather than submit a vague "heart health" request.
Check eligibility for FEP's free weight program → For weight-management coverage, program participation is a box FEP checks at the start and again at renewal.
How do I get a GLP-1 approved on FEP Blue, and who can help?
To get a GLP-1 approved on FEP Blue, your prescriber sends the required records to CVS Caremark, which runs FEP's pharmacy benefit. A listed drug can need prior approval; an unlisted drug can need a formulary exception and clinical approval. Caremark describes electronic requests as potentially taking minutes to hours and fax or phone requests about 16 hours to 3 days. Those are processing estimates, not a promise of approval or a prescription in hand. FEP request process · Exception instructions
The 6 steps, in order
- Know your option. Your card says Standard, Basic, or Focus. Check whether you're FEHB or PSHB, and whether Medicare pays first.
- For weight-management requests, start a qualifying program. FEP checks for it at the start and at every renewal. Diabetes and MASH requests have their own criteria.
- Pick who writes the prescription. Your own doctor, or another clinician who confirms they can prescribe and handle FEP paperwork. See the table below.
- Your prescriber files the right request. Ask whether prior approval, a formulary exception, or both are needed. Electronic filing can be faster, but complete records still matter. The traditional FEP prescriber line is 1-877-727-3784.
- Compare the actual fill prices. On Standard, check whether Mail Service can fill your prescription under its published benefit. On every option, compare the approved price with eligible cash pricing and extra care fees.
- Set a reminder before the approval ends. For a six-month weight-management approval, month 5 is a useful time to ask about renewal.
Prior approval or formulary exception?
| Question | Prior approval | Formulary exception |
|---|---|---|
| When you need it | FEP needs proof that you meet the drug's clinical rules | The drug is unlisted, excluded, or Managed Not Covered and you are requesting coverage |
| FEP GLP-1 examples | Wegovy and Saxenda on Standard/Basic; listed liraglutide; diabetes GLP-1s | Zepbound on all three options; Wegovy on Focus |
| What your prescriber sends | The required diagnosis, clinical records, and treatment information | Why covered alternatives are unsuitable, plus the drug-specific clinical information |
| What you pay if approved | The applicable drug benefit and tier | The assigned exception tier: Zepbound Tier 3 on Standard/Basic; Wegovy or Zepbound Tier 2 on Focus |
| Can this request lower my tier? | No; clinical approval does not change the formulary tier | FEP does not allow GLP-1 tier exceptions |
| How long it lasts | Weight-management Wegovy/Saxenda: initially 6 months, then 12; diabetes drugs: 12 months; MASH: 12 months | Zepbound's published weight-management policy: initially 6 months, then 12; check the actual exception end date |
These are not always either/or choices. A non-formulary drug still has clinical criteria. Ask your prescriber to complete the exception and approval information required for your option. FEP FAQ · Zepbound request form
For the full walk-through, see how a GLP-1 formulary exception works.
What to say when you call FEP or Caremark
Copy this, fill in the blanks, and write down the reference number:
"I have FEP Blue [Standard / Basic / Focus] through [FEHB / PSHB], with [traditional pharmacy benefits / MPDP]. Can you check [drug, form, strength, and number of days] at [my pharmacy / Mail Service]? Is it on my list for [the diagnosis my clinician is treating]? Do I need prior approval, a formulary exception, or both? What records do you need? What will I pay after approval? Does a special diabetes benefit apply? When does approval end? Can I have a reference number?"
Numbers to use: Retail Pharmacy Program 1-800-624-5060 · Mail Service Pharmacy 1-800-262-7890 · Traditional FEP prescriber prior-approval line 1-877-727-3784 · MPDP member line 1-888-338-7737. MPDP prescribers use 1-855-344-0930 for prior approval. FEP contacts · MPDP information
Who can write the prescription and file the paperwork?
Start with the clinician you already see. A paid membership can help with the work, but it does not change FEP's rules.
| Treatment path | Who handles the FEP paperwork | Extra cost to you | Best for | Watch out for |
|---|---|---|---|---|
| Your own doctor | Your doctor's office, if it offers this service | Your normal visit cost and any disclosed office fee | People whose doctor already files prior approvals | Ask who submits the request and follows up |
| FEP's general telehealth benefit | Ask before booking; GLP-1 prescribing and PA support were not verified | Covered Teladoc visits are listed at $0 on FEP's comparison page | Checking available care from home | A covered telehealth visit is not proof of GLP-1 treatment access |
| Ro | Ro says its insurance concierge files and follows up for supported medicines | $39 first month; then $149 monthly or as low as $74 per month with annual prepayment; medicine separate | People who want dedicated paperwork help and a branded cash option in the same place | FEHB support is stated; PSHB members should confirm. Insurance help covers selected pens only |
| Sesame | The selected clinician; Sesame says its program includes PA assistance | Month-to-month from $99 billed every 28 days; lower advertised annual-prepay rate; medicine separate | People who want to pick their own clinician | The care fee is not billed to insurance; it does not prescribe controlled weight-loss medicines |
Sources: FEP plan comparison, Ro pricing, Ro insurance support, and Sesame program terms. Checked September 22, 2026. Ro and Sesame links on this page may be affiliate links.
Already know your option? Compare the prescriber questions in our Standard, Basic, or Focus guide.
Ro: let someone else fight the paperwork
Ro's insurance concierge checks your FEP benefits, submits the prior approval, and sends your prescription to your pharmacy once coverage is set. Ro says this typically takes 1 to 3 weeks. If FEP says no, Ro's providers can suggest FDA-approved cash options instead. Get started for $39, then as low as $74/month with annual plan paid upfront ($149 month to month). Ro says the $39 is refunded if you're not eligible for GLP-1s. Ro's service description · Current prices
Here's the honest part. Ro does NOT lower what FEP charges you for the drug, and insurance doesn't pay for Ro's membership. If paying the least is your top priority, using your own doctor avoids a separate Ro subscription; Standard members should also compare an eligible mail-service quote. But because the membership pays for a dedicated insurance concierge, Ro's team files the prior approval and handles the back-and-forth with FEP for you. And if coverage falls through, Ro can move you to FDA-approved cash pricing, so you don't have to start over somewhere else. Treatment still depends on the clinician's decision. Ro's insurance terms
Keep the product limit straight: Ro's current insurance-supported selection is the Wegovy pen, Zepbound single-dose autoinjector pen, and Ozempic pen. Its Wegovy pill and Zepbound KwikPen are cash-pay options. A tablet on FEP's list does not mean Ro can use your insurance for it. Supported medicines
"I was thrilled to not have to fight for my coverage." — Hannah, Ro member Paid testimonial published by Ro, which says its members were paid for their testimonials. Hannah's insurer isn't named, and her story doesn't show how often FEP approves requests. Ro's testimonial and disclosure.
Check your FEP Blue pen coverage free with Ro → (sponsored) The free check covers the Wegovy, Zepbound, and Ozempic pens. It requires your insurance details; it is not a prescription, prior approval, or a paid membership. What the checker does
Skip Ro if you already have a doctor who files prior approvals and your goal is the lowest total cost. Use the FEP call script and price-check card above instead.
Sesame: choose your own clinician
Sesame is a marketplace. You choose the clinician and see the price before you book. Its weight-loss program is a subscription that insurance doesn't pay for. Your prescribed medicine may still be covered by FEP, and Sesame says its clinicians can help with prior authorization. Before you pay, confirm that the clinician you pick will handle FEP's paperwork for your drug. Sesame's program
The month-to-month program starts at $99 billed every 28 days, not once per calendar month; some clinicians charge more. Thirteen charges cover 364 days and total $1,287 before medication at that starting rate. Sesame also advertises $59 per month with annual prepayment. That is a longer commitment, not the month-to-month rate. Pricing and billing terms
One FEP-specific catch: Sesame says it does not prescribe controlled weight-loss drugs, including phentermine and Qsymia. If those are part of your clinician's plan for addressing FEP's Zepbound steps, ask who will handle that care before you subscribe. Do not take an unsuitable drug just for insurance. Sesame's medication limits
Sesame says you can receive a full refund if you cancel at least three hours before the initial appointment. After that first visit, the first month's fee is nonrefundable; cancel before the next billing date to avoid another charge. Check the terms of any prepaid plan before choosing it. Cancellation terms
Compare Sesame's clinicians and program price → (sponsored)
Provider-stated versus verified: what these offers prove
| Claim | What we confirmed in public sources on September 22, 2026 | What was not independently tested |
|---|---|---|
| Ro handles FEHB insurance paperwork | Ro expressly describes FEHB support and its concierge service | A real FEP submission, approval rate, or promised result |
| Ro has a free coverage checker | The public tool lists supported pens and describes its coverage report | A completed report for a member or a resulting claim |
| Ro advertises manufacturer-matching drug prices | Its displayed Wegovy dose prices match the NovoCare offers compared above; membership is additional | Every checkout, state, or eligibility situation |
| Sesame offers clinician choice and PA help | Both are stated on its program page, along with the subscription and medication limits | A selected clinician's handling of an FEP case |
| A lower prepaid membership rate saves money | A lower effective rate is advertised | Whether a long commitment fits your care needs or unused time would be refundable |
Sources: Ro pricing, Ro insurance, Ro checker, NovoCare, and Sesame. Public terms are evidence of the offer—not evidence that we used the service.
Does FEP Blue cover Zepbound?
FEP Blue covers Zepbound only through an approved formulary exception under the traditional benefits discussed here. It's on Standard's Excluded list and Basic's Managed Not Covered list, and it isn't on the Focus list. For weight management, FEP's criteria include two oral-drug steps and preferred alternatives; the request form separates Standard/Basic from Focus. FEP FAQ · Zepbound criteria · Request form
The Zepbound checklist (printable)
- [ ] 18 or older
- [ ] Diagnosis: use the correct clinical path. The checklist below summarizes weight management; sleep apnea needs the separate document check below.
- [ ] BMI of 30 or more, or 27 or more with established heart disease or a qualifying weight-related condition like type 2 diabetes, high cholesterol, or high blood pressure
- [ ] At least two oral weight-loss drugs that didn't work well enough, caused side effects you couldn't handle, or aren't safe for you. FEP's examples include benzphetamine, diethylpropion, phentermine, and Qsymia.
- [ ] Your option's preferred alternatives: Standard/Basic's form asks about Saxenda (liraglutide) AND Wegovy. Focus has a separate formulary-alternatives branch that names generic Saxenda (liraglutide). Document inadequate response, intolerance, or a medical reason not to use the required alternatives.
- [ ] In a comprehensive weight management program (Teladoc or another program)
- [ ] No doubling up with another GLP-1 or another weight-loss drug that needs prior approval
- [ ] Records that prove each item, like visit notes and lab reports
- [ ] Your prescriber files FEP's formulary exception request
- [ ] Know this up front: FEP's policy says being on Zepbound now, even from samples, doesn't guarantee approval
Sources: FEP policy 5.99.031, effective July 1, 2026; FEP's preferred-product list; and Zepbound request form. Checked September 22, 2026.
Never take a drug that isn't safe for you just to check a box. A medical reason you can't take a drug counts, and your prescriber documents it.
Why this list matters: FEP's preferred-product list names two drugs: Saxenda (liraglutide) and Wegovy. But its request form gives Focus a separate branch. Do not make a Focus member follow a Standard/Basic checklist without first confirming the current Focus requirements. Preferred products · Form branches
What does Zepbound cost if FEP approves it?
An approved exception puts Zepbound at Tier 3 on Standard and Basic, and Tier 2 on Focus. The exception does not grant a lower tier. FEP FAQ
| Where you fill it | Published drug-cost rule | What still needs checking |
|---|---|---|
| Standard, regular pharmacy | 50% of FEP's allowance | Actual approved claim price, savings eligibility, and remaining yearly protection |
| Standard, eligible mail order | Section 5(f): 20%, up to $250 for more than 21 days and up to 90 days | Whether Mail Service can supply your exact prescription and which rule it applies |
| Basic, regular pharmacy | 60% of FEP's allowance | Final claim price versus an eligible cash offer |
| Focus, regular pharmacy | 40%, up to $500 for 30 days or $1,300 for up to 90 days | Exception approval and approved supply |
| Cash Zepbound KwikPen | $299 at 2.5 mg; $399 at 5 mg; $449 at 7.5–15 mg under the qualifying purchase offer | Higher-dose offer has a 45-day refill condition; care fees are separate |
Sources: FEP benefit rules, Focus brochure, Lilly's current offer, and Ro's displayed prices. Checked September 22, 2026. Cash KwikPen and covered single-dose pens are different presentations; do not compare the price without identifying the product.
The $449 catch matters. Lilly grants the offer on a qualifying first 7.5, 10, 12.5, or 15 mg KwikPen purchase. To keep it, the next purchase must be within 45 days of delivery or receipt of the previous fill. Without that offer, Lilly lists $499 for 7.5 mg and $699 for 10, 12.5, or 15 mg. A KwikPen supply is 28 days. The 2.5 mg dose is a starting dose, not a labeled maintenance dose. Offer terms · Zepbound label
FEP's published quantity limit is written for single-dose pens, 12 per 84 days, so ask before you assume the KwikPen or vials are covered. FEP policy
I'm already on Zepbound. Will FEP keep paying?
Not automatically. FEP's policy says current use, even from samples, doesn't guarantee approval. If you already have an approved exception, FEP says it honors it until it ends. Put the end date on your calendar, and have your prescriber ask when renewal can be filed, with your records. Policy · Exception FAQ
What if I can't meet FEP's Zepbound steps?
- Ask about a listed treatment. Wegovy, Saxenda, and weight-management generic liraglutide are listed on Standard and Basic; Focus lists the generic. Your clinician decides which is medically suitable.
- Compare cash for FDA-approved Zepbound. The KwikPen's advertised $299–$449 range has dose and offer conditions, and Ro's membership is separate.
- Have sleep apnea? Use the document check below rather than assume that FEP covers only weight management.
See Ro's Zepbound cash prices → (sponsored) At Ro, the KwikPen is cash-only, and the care membership costs extra. Ro's terms
Does FEP Blue cover Zepbound for sleep apnea?
Zepbound is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity. FEP's public documents do not give one consistent approval path for it. Its request form includes that diagnosis, while the linked clinical criteria set out a weight-management pathway without a separate OSA checklist. FDA-approved label · FEP request form · FEP policy
| Document we checked | What it says | What that establishes |
|---|---|---|
| Zepbound FDA-approved label | Includes moderate to severe OSA in adults with obesity | This is an approved use, not an unapproved use of the drug |
| FEP Zepbound request form, revised January 1, 2026 | Includes an OSA-with-obesity diagnosis choice | FEP's form accepts that reason for the request |
| Linked FEP policy 5.99.031, effective July 1, 2026 | Provides detailed weight-management criteria, without a separate OSA approval section | The public policy does not settle an OSA-specific benefit decision |
Ask FEP: "My clinician is treating moderate to severe OSA with obesity. Which Zepbound exception criteria apply under my exact benefit, and which sleep-study and clinical records do you need? Please send the criteria in writing."
Your clinician can also check whether the documented facts meet the weight-management criteria. Do not change or hide the reason for treatment to get around a coverage rule. MPDP members need the separate Medicare review.
Related: Blue Cross Zepbound prior authorization · Does FEHB cover Zepbound?
What does FEP Blue Focus cover for GLP-1s?
FEP Blue Focus uses a closed list: listed drugs can be covered, and unlisted drugs need an approved exception. For weight loss, generic liraglutide is Tier 1 with prior approval. Wegovy and Zepbound need a formulary exception and land at Tier 2 if approved. Focus formulary · FEP FAQ
| Question | Traditional FEHB Focus answer (2026) |
|---|---|
| Weight-loss GLP-1 on the list | Generic liraglutide: Tier 1 with prior approval; $5 for up to 30 days or $15 for 31–90 days at a Preferred retail pharmacy |
| Wegovy single-dose pen, pill, or HD 7.2 mg | Not routinely listed; FEP describes Wegovy exceptions at Tier 2. Confirm the exact product in the decision |
| Zepbound | Not listed; exception, then Tier 2, with option-specific requirements |
| Brand Saxenda and Victoza | Not on the list |
| Diabetes GLP-1s | Ozempic, Mounjaro, Rybelsus, Trulicity: Tier 2 with prior approval |
| Tier 2 cost | 40%, up to $500 for 30 days or $1,300 for up to 90 days |
| Mail order | Not offered |
| FEP's Medicare drug plan (MPDP) | Not available with FEHB Focus; do not apply that statement to PSHB Focus |
| Deductible | $750 Self Only or $1,500 Self Plus One/Family for applicable benefits; it does not apply to these Tier 1 and Tier 2 prescriptions |
| 2026 premium, Self Only | $66.81 every two weeks for the FEHB employee share, the lowest of the three FEHB options |
Sources: Focus brochure, Focus formulary, FEP FAQ, and 2026 rates.
The Focus math: Focus has the lowest FEHB premium, but that does not make an exception-only Wegovy prescription the cheapest treatment path. For example, a confirmed $500 covered 28-day fill would be $151 more than an eligible $349 drug-only cash box. A confirmed $1,300 covered 84-day fill would be $253 more than three $349 boxes. These are comparisons at the caps, not your price quote. Include premiums, extra care fees, and yearly out-of-pocket protection before comparing options during Open Season.
More: GLP-1 prescribers for FEP Blue Focus
Does FEP Blue cover Ozempic or Mounjaro for type 2 diabetes?
FEP Blue lists Ozempic shots and tablets, Mounjaro, Rybelsus, and Trulicity for type 2 diabetes at Tier 2, with prior approval, on Standard, Basic, and Focus. An initial request needs the documented diagnosis and supporting evidence. FEP's current policy does not require a metformin trial, and it does not cover these drugs for weight loss alone under that diabetes policy. Formularies · Policy 5.30.086
| What FEP needs | FEP's rule (policy 5.30.086) |
|---|---|
| Diagnosis | Type 2 diabetes |
| Initial supporting evidence: one qualifying result or documented history specified by the policy | A1C of 6.5% or higher; fasting blood sugar of 126 mg/dL or higher; a 2-hour glucose tolerance test of 200 mg/dL or higher; or symptoms of hyperglycemia or hyperglycemic crisis with random blood sugar of 200 mg/dL or higher |
| Metformin first? | No metformin trial appears in the current initial-approval criteria |
| Weight loss only? | Not covered under this type 2 diabetes policy |
| Renewal | Improved or stabilized blood-sugar control, plus the other continuation criteria |
| How long approval lasts | 12 months |
Source: FEP's current diabetes GLP-1 criteria.
A good lab result during treatment does not mean you need to become uncontrolled again. The renewal rule is different from the initial diagnostic evidence. Give your prescriber the original diagnosis records and current response; do not stop treatment to make a lab number rise.
Why Ozempic coverage doesn't answer the Wegovy question
Wegovy and Ozempic both contain semaglutide. Mounjaro and Zepbound both contain tirzepatide. But FEP covers each pair under different rules. Ozempic and Mounjaro follow the diabetes rules above. Wegovy and Zepbound have separate policies, including the weight-management rules discussed here. So "FEP covers Ozempic" does not tell you whether FEP will cover Wegovy for you. FEP diabetes policy · Wegovy policy · Zepbound policy
Costs for these drugs are in the diabetes cost table above. On a state Blue Cross plan instead? See does Blue Cross cover Ozempic. On another federal plan? See does FEHB cover Mounjaro.
I'm on PSHB or have Medicare. What's different?
FEP Blue's Postal Service (PSHB) members have their own versions of Standard, Basic, and Focus, and some drug prices differ. In 2026, PSHB Standard lists mail copays of $140 for preferred brands and $175 for non-preferred brands. If you're in FEP's Medicare Prescription Drug Program (MPDP), use its own drug list and rules, not the traditional tiers on this page. PSHB benefits · MPDP
PSHB: what's different
| Benefit | Traditional FEHB Standard | Traditional PSHB Standard |
|---|---|---|
| Mail order, preferred brand (Tier 2) | Section 5(f): 15%, up to $150 per eligible fill | Published $140 copay |
| Mail order, non-preferred brand (Tier 3) | Section 5(f): 20%, up to $250 per eligible fill | Published $175 copay |
| 2026 employee premium, Self Only, every two weeks | $188.32 | $190.10 |
Do not turn the $175 benefit into a confirmed Wegovy fill. Ask Mail Service whether it can dispense your exact prescription, how many days the fill covers, and which copay applies. If it confirms an 84-day fill at $175, the drug-only cost would be $14.58 per week. We did not obtain that quote.
PSHB Basic and Focus employee premiums in 2026 are $127.59 and $75.15 every two weeks for Self Only. FEP's formulary exception form covers both FEHB and PSHB. For PSHB Basic mail eligibility, use the PSHB benefit materials; its comparison page ties that benefit to MPDP enrollment, not the traditional FEHB Basic rule used above. PSHB comparison · FEP form
Sources: FEP's 2026 FEHB and PSHB rates and benefits and PSHB plan comparison. Checked September 22, 2026.
Medicare and MPDP
- If you're in MPDP, FEP's Medicare Part D plan, your GLP-1 follows MPDP's four-tier list. Its 2026 out-of-pocket maximum is $2,100 per member for costs that count under Part D, not a cap on premiums or every cash purchase. FEP MPDP
- The commercial Wegovy savings card can't be used with MPDP. Manufacturer cash offers are separate and have their own restrictions. Novo terms
- If you're on traditional FEHB Basic and Medicare Part B is primary, Mail Service becomes available under that benefit. The ordinary mail Tier 2 rate is 35%, up to $225; Tier 3 is 35%, up to $250. The ordinary retail Tier 2 cap is $100 for up to 30 days or $300 for 31–90 days. These are not MPDP prices. Medicare-adjusted benefits
- FEHB Focus members can't join MPDP. PSHB Focus is different; use the Postal benefit page. MPDP members can call 1-888-338-7737. MPDP · PSHB comparison
What about the $50 Medicare GLP-1 Bridge?
The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027 for eligible Part D members who meet its criteria. It charges $50 per monthly supply and operates outside the regular Part D benefit. That $50 does not count toward the Part D out-of-pocket limit. It is not automatic coverage for every Medicare member. CMS program rules
The listed products are Foundayo, Wegovy injections and tablets, and Zepbound KwikPen—not the Zepbound single-dose pens or vials. A prescription for a condition covered through ordinary Part D, such as qualifying diabetes or OSA treatment, needs the regular benefit check instead. Medicare's product list · CMS guidance
Check the Medicare GLP-1 Bridge requirements → Our Medicare GLP-1 Bridge guide walks through the application questions.
Will FEP Blue still cover GLP-1s in 2027?
OPM told FEHB and PSHB plans to keep covering at least one weight-loss GLP-1 and two oral weight-loss drugs for 2027. It also called for documented participation in a lifestyle program with human interaction before and during treatment. That sets a coverage floor—not a promise about Wegovy's or Zepbound's tier, price, or approval on your option. OPM's 2027 letter
At this September 22, 2026 check, the FEP public benefit pages reviewed still showed 2026 information. We did not verify a final 2027 FEP formulary or member price. Do not use the 2026 table as a 2027 quote. FEP comparison
What OPM's 2027 letter says, in plain words
OPM set out its 2027 instructions in Carrier Letter 2026-07 on March 31, 2026:
- Coverage stays. Plans must cover at least one GLP-1 for obesity and at least two oral weight-loss drugs.
- Participation must be documented. The letter calls for intensive behavioral therapy, or IBT, before and during drug treatment, with proof of participation. A signed statement alone should not bypass the requirements.
- Human support matters. App-only or AI-only programs do not meet the letter's standard; it calls for human interaction and accommodations for members with physical impairments.
Source: OPM Carrier Letter 2026-07. These are instructions to plans; FEP's final member-facing criteria still need checking.
What it means for you: if you plan to start or stay on a GLP-1 in 2027, keep your weight-program records. Before paying for a program, ask FEP which 2027 program and documentation requirements it will apply.
Wegovy's list price drops on January 1, 2027
Novo Nordisk announced that the U.S. list price for the Wegovy products covered by its announcement will fall to $675 on January 1, 2027, from $1,349.02. Its announcement includes Wegovy 2.4 mg and the 25 mg pill; do not assume a later product or dose has identical terms. List price is not FEP's Plan allowance, your copay, or the manufacturer cash offer. Novo Nordisk's February 24 announcement
Here is what the percentage math would look like only if FEP's allowance equaled the shown amount and the 2026 rules stayed unchanged. This is a scenario, not a forecast or 2027 benefit quote.
| Where you fill it | With an assumed $1,349.02 allowance per 28-day box | With an assumed $675 allowance per 28-day box |
|---|---|---|
| Standard, ordinary retail Tier 3, 50% | $674.51 | $337.50 |
| Standard, eligible 84-day mail fill, 20% capped at $250 | $250 cap | $250 cap; 20% of three $675 boxes is $405 |
| Basic, ordinary retail Tier 3, 60% | $809.41 | $405 |
| Focus, approved retail exception, 40% capped at $500 | $500 cap | $270 |
These calculations exclude savings cards, separate care fees, and annual out-of-pocket protection. The announced list-price cut does not establish a lower personal FEP bill. Recheck the final tier, benefit, allowance, and cash offer for the same prescription before deciding.
Your Open Season checklist for 2027
- Watch for FEP's 2027 numbers. OPM's final formulary-submission deadline is October 15, 2026. That is a deadline for plans, not a guarantee that a specific member-facing list will appear on that date. Technical guidance
- Look up your drug's 2027 tier on each option.
- Add it up. Your premium plus covered care and drug costs, subject to the applicable yearly limits, plus any spending outside the plan.
- Check which weight programs count in 2027.
- Mark Open Season: November 9 to December 14, 2026. These dates are published on the U.S. Department of Veterans Affairs employee benefits page. Official dates
- Before you switch options, ask FEP whether your current approval carries over. Confirm the enrollment-change effective date with your benefits office; do not assume every employee's change starts January 1.
The timeline, from OPM's letter to your new plan year
| Date | Published event or target |
|---|---|
| March 31, 2026 | OPM issued the 2027 carrier instructions |
| May 31, 2026 | OPM deadline for plan benefit proposals |
| July 31, 2026 | OPM target for completing benefit negotiations |
| Mid-August 2026 | OPM target for settling rates |
| September 18, 2026 | OPM brochure-finalization deadline |
| October 15, 2026 | Final formulary-submission deadline |
| November 9 to December 14, 2026 | Published 2026 Federal Benefits Open Season dates |
| December 31, 2026 | Current deadline to redeem each qualifying $199 Wegovy starter-offer fill |
| January 1, 2027 | Novo's announced list-price change takes effect; check your own enrollment effective date separately |
Sources: OPM's call letter and technical guidance, official Open Season information, Novo's announcement, and Wegovy offer terms. Administrative targets are not a claim that FEP completed each task on that date.
What if FEP Blue denies my GLP-1?
If FEP Blue denies your GLP-1, start with the reason on the denial letter, because the fix depends on it. A missing record, an unmet clinical rule, an excluded drug, and an expired approval are different problems. For traditional FEHB benefits, Sections 3 and 8 explain reconsideration and OPM review. PSHB members need the matching Postal brochure; MPDP uses its separate Medicare appeal process. FEHB brochure · PSHB benefits · MPDP
| What the letter says, in plain words | What to check | What to do |
|---|---|---|
| BMI rules not met | Was the required dated BMI or qualifying condition documented, and does it meet the rule? | Send missing records; if the criteria are not met, discuss another appropriate path with the prescriber |
| No weight program | Did the request include acceptable participation information? | Send program records or ask which qualifying program is needed |
| Not on formulary, or excluded | Was an exception requested, and why was it denied? | Ask about the correct exception form and required evidence; an exception is not guaranteed |
| Step therapy not met, Zepbound | Were the option-specific alternatives and oral-drug criteria addressed? | Send dates, doses, results, or medical reasons those treatments are unsuitable |
| Renewal: response not shown | Does the request use the correct adult, pediatric, diabetes, or MASH renewal rule? | Send baseline and current records that answer that rule |
| Quantity limit | Does the exact form and amount fit the policy? | Ask about an appropriate quantity or a medically supported quantity review |
| Not covered for this use | Does the requested diagnosis fit this benefit and policy? | Request the written rule; for Zepbound OSA, ask FEP to resolve the form/policy mismatch |
| Wrong plan line | Was an MPDP request sent through the traditional FEP process, or the reverse? | Use the correct benefit's line and form |
How to appeal (Sections 3 and 8 of the FEHB brochure)
For a traditional FEHB claim, Section 3 covers a denial before treatment or dispensing; Section 8 covers a claim after care and the OPM review steps.
- Ask FEP to reconsider, in writing, within 6 months of the denial. Include the denial and the records that address its reason.
- If FEP upholds the denial, ask OPM to review within 90 days of that answer.
- If FEP does not answer, do not wait forever. Section 8 allows an OPM request within 120 days after you first asked for reconsideration if FEP did not respond in any way within 30 days. It also allows 120 days after FEP requested more information if it did not decide within 30 days after receiving that information.
- If waiting could seriously harm your health, ask about urgent review. The brochure permits simultaneous OPM review of qualifying urgent claims rather than always waiting through the normal sequence.
These are traditional FEHB instructions from Sections 3 and 8, not MPDP appeal deadlines. PSHB members should use the matching Postal benefit materials. Your denial notice identifies the process for your claim.
Use the free GLP-1 appeal letter template → Match the template to FEP's written reason and deadlines; a template does not establish medical need.
Helpful next reads: how a formulary exception works · documents your prescriber needs
How we checked this
This guide is built from FEP's own documents, not summaries of them: the 2026 brochures, GLP-1 prior-approval policies, preferred-drug list, request forms, update log, and drug lists. We assembled the comparisons and did the labeled calculations ourselves. We didn't file a real prior approval, so FEP and CVS Caremark have the final word on your coverage.
| Source | What we used it for | Version or date |
|---|---|---|
| FEP Standard and Basic brochure, Sections 3, 5(f), and 8 | Cost rules, special diabetes benefits, annual protection, and appeals | 2026 plan year |
| FEP Blue Focus brochure | Retail copays, no prescription deductible, and annual protection | 2026 plan year |
| Full Standard, Basic, and Focus formularies | Exact product listings and tiers | Current 2026 files checked September 22 |
| Wegovy/Saxenda policy 5.99.030 | Adult, pediatric, renewal, MASH, and quantity criteria | Published 2026 policy checked September 22 |
| Zepbound policy 5.99.031, request form, and preferred list | Option-specific alternatives, oral-drug steps, and the OSA document mismatch | Policy/preferred list effective July 1, 2026; form revised January 1, 2026 |
| Diabetes GLP-1 policy 5.30.086 | Initial diagnostic evidence, renewal, and quantity rules | Current 2026 policy checked September 22 |
| FEP PA updates and pharmacy FAQ | Published changes, exceptions, tiers, and contacts | Checked September 22, 2026 |
| Caremark FEP prior-approval page | Advertised processing times | Checked September 22, 2026 |
| FEP rates, FEHB comparison, PSHB comparison, and MPDP | Premiums and benefit differences | 2026 information checked September 22 |
| OPM call letter and technical guidance | 2027 instructions and administrative deadlines | March 31, 2026 |
| VA's Federal Benefits Open Season page | Published November 9–December 14, 2026 dates | Checked September 22, 2026 |
| CMS Bridge rules and Medicare drug list | Bridge dates, products, eligibility limits, and $50 charge | Checked September 22, 2026 |
| NovoCare prices, offer terms, and Novo's 2027 announcement | Dose-specific cash prices, savings conditions, and announced list-price change | Checked September 22; announcement February 24, 2026 |
| Lilly Zepbound offer | KwikPen prices and 45-day refill condition | Checked September 22, 2026 |
| Wegovy, Saxenda, and Zepbound prescribing information; FDA Foundayo notice | Approved uses, ages, product distinctions, and safety | Current documents checked September 22 |
| Ro pricing, insurance, checker, and testimonial page | Fees, supported products, provider-stated services, and paid testimonial | Checked September 22, 2026 |
| Sesame program page | Subscription, billing period, PA support, medication limits, and cancellation | Checked September 22, 2026 |
What we didn't do: file a real prior approval, check a pharmacy's stock, get a patient price quote, or test a provider's signup or cancellation. Public service claims remain provider-stated, even when their wording and terms are verified.
Who we are: The RX Index, independent guidance for choosing your GLP-1 path. We're not affiliated with FEP, the Blue Cross Blue Shield Association, CVS Caremark, or OPM. The table design, call script, comparison calculations, and decision checklists were assembled for this guide; the linked organizations set the underlying rules.
What the verification date means: September 22, 2026 is the date of this public-source check, not the publication date or effective date of every policy. Future plan lists, updated approval rules, manufacturer offers, or provider fees can change the answer. Use the current linked source and a fresh exact-product quote before paying.
Document conflicts are shown, not hidden. We did not turn the mail-order summary mismatch or the Zepbound OSA form mismatch into a made-up coverage answer.
FEP Blue GLP-1 FAQ
These are quick answers to the FEP Blue GLP-1 questions covered above. Use the same benefit type, medication form, and diagnosis when comparing answers.
What GLP-1 does FEP Blue cover?
For weight loss, FEP Blue Standard and Basic list Wegovy single-dose pens, tablets, and HD 7.2 mg, plus Saxenda, at Tier 3 with prior approval. All three options list weight-management generic liraglutide at Tier 1. Focus needs an exception for Wegovy, and every option needs one for Zepbound. For type 2 diabetes, Ozempic, Mounjaro, Rybelsus, and Trulicity are Tier 2 with prior approval on all three. Lists · Exceptions
Does FEP Blue cover Wegovy?
Yes, with prior approval. It's Tier 3 on Standard and Basic. On Focus, it needs a formulary exception and is Tier 2 if approved. Confirm the exact presentation in the approval; a pen approval does not automatically cover a pill or another dose. FEP lists · Exception tiers
Does FEP Blue cover Zepbound?
Only through an approved formulary exception under these traditional FEP benefits. The weight-management criteria include two oral-drug steps. Standard/Basic's form also asks about both Saxenda and Wegovy; Focus has a separate alternatives branch. Medical reasons not to use an alternative can be documented. If approved, Zepbound is Tier 3 on Standard/Basic and Tier 2 on Focus. Policy · Form · Tiers
How much is Wegovy with FEP Blue Standard?
At a Preferred retail pharmacy, the ordinary Tier 3 cost share is 50% of FEP's allowance, without a per-fill dollar cap. Section 5(f) lists eligible mail fills at 20%, up to $250, for more than 21 days and up to 90 days. We did not confirm that Mail Service can supply your Wegovy prescription or obtain your price. Benefit rules
How much is Wegovy with FEP Blue Basic?
At a Preferred retail pharmacy, ordinary Tier 3 cost sharing is 60% of FEP's allowance, without a per-fill dollar cap. That is not a guaranteed $809 box. Traditional FEHB Basic has mail eligibility only with Medicare Part B primary; PSHB rules differ. Compare your approved claim with eligible cash pricing for the exact product and supply. FEHB brochure · PSHB benefits
Does FEP Blue Focus cover any weight-loss GLP-1?
Yes. Generic liraglutide for weight management is Tier 1 on Focus, with prior approval. The ordinary Preferred-retail copay is $5 for up to 30 days or $15 for 31–90 days, without a prescription deductible. Wegovy and Zepbound need a formulary exception. Focus list · Focus benefits · Exceptions
Does FEP Blue cover Ozempic for weight loss?
Not under FEP's type 2 diabetes approval policy. An initial Ozempic request needs the documented diabetes diagnosis and the required supporting evidence. For weight loss alone, ask your prescriber about a listed weight-management product rather than assume Ozempic's listing applies. FEP diabetes policy
Does FEP Blue make me try metformin before Ozempic or Mounjaro?
No metformin trial is required in the current FEP initial-approval criteria reviewed. You still need the type 2 diabetes diagnosis and supporting evidence. Renewal asks about improved or stabilized blood-sugar control, not a fresh high diagnostic result. Current policy
Does FEP Blue cover the Wegovy pill?
Yes, on Standard and Basic, at Tier 3 with prior approval, for adults 18 and up. On Focus, it needs an exception. Current cash offers are $149 for 1.5 mg, $199 for 4 mg, and $299 for 9 or 25 mg per 30-tablet supply. Compare the prescribed dose with your actual FEP quote; the cheapest starter price is not a maintenance-price promise. Lists · NovoCare · Label
Does FEP Blue cover Foundayo?
We did not find it in the full 2026 lists, GLP-1 approval policies, or update log reviewed on September 22, 2026. Ask FEP for a current exact-product check and any exception criteria. A search of the public list is not a written member coverage decision. FEP lists · Updates
Does a covered Wegovy pill mean Ro can bill FEP for it?
No. FEP's drug list and Ro's insurance help are two separate things. Ro's insurance help covers selected Wegovy, Zepbound, and Ozempic pens, and Ro sells the Wegovy pill as cash-pay only. Ro's supported products
What weight program does FEP Blue require?
For weight-management approval, FEP asks for a comprehensive program at the start and renewal, with Teladoc as one example. FEP offers its Teladoc program at no cost to eligible members age 13 or older who meet the listed claim-based eligibility requirements. The age-12 drug pathway needs a different acceptable program when the child is not eligible for Teladoc. Policy · Program
How long does FEP Blue approve Wegovy for?
For weight management, six months at first, then 12 months when renewal criteria are met. Adult renewals use at least 5% baseline weight loss or maintenance of the initial qualifying loss; pediatric renewals use a separate response standard. Wegovy's MASH pathway uses 12-month initial and renewal approvals. FEP policy
How long does FEP Blue prior approval take?
CVS Caremark describes electronic requests as potentially taking minutes to hours, and fax or phone requests about 16 hours to 3 days. These are processing estimates, not a guaranteed turnaround for your complete treatment process. Ask when your complete request was received, what is missing, and when a decision is due. FEP prior-approval page
Does prior approval mean my pharmacy has the drug?
No. Approval and stock are separate. Once you're approved, ask your pharmacy or FEP's Mail Service whether they can fill the exact prescription. FEP's brochure states that not all drugs are available through Mail Service. Pharmacy benefits
Can I use the Wegovy savings card with FEP Blue?
Eligible FEHB members can use the commercial offer because Novo does not classify FEHB as government insurance for that offer. MPDP is excluded. The current maximum saving is $100 for one qualifying month's supply, with higher limits for longer supplies. Confirm all terms and ask how FEP counts the savings toward your yearly costs. Novo eligibility and limits
Is paying cash for Wegovy cheaper than using FEP Blue?
Sometimes. Compare the actual approved price with the eligible cash price for the same drug and days supplied, including any extra care fee. Do not decide from list-price estimates. A confirmed eligible Standard mail fill may be lower, and yearly out-of-pocket protection can also change the choice. Manufacturer self-pay purchases do not count toward that insurance limit under the offer's terms. FEP rules · Cash terms
Does FEP Blue cover Zepbound for sleep apnea?
FEP's documents need a case-specific check: the Zepbound request form includes moderate to severe OSA with obesity, but the linked policy provides no separate OSA approval checklist. Ask FEP for written OSA-specific exception criteria under your benefit. This is an FDA-approved Zepbound use—not proof of automatic FEP approval or denial. Form · Policy · Label
Will FEP Blue cover GLP-1s in 2027?
OPM requires FEHB and PSHB plans to cover at least one obesity GLP-1 and two oral weight-loss drugs for 2027, with documented lifestyle-program participation. That does not identify your specific drug's final 2027 tier or price. Check FEP's final member-facing materials before making a plan choice. OPM letter
Does FEP Blue cover GLP-1s for Postal Service (PSHB) members?
PSHB has its own Standard, Basic, and Focus options, and some costs differ. PSHB Standard publishes mail copays of $140 for preferred brands and $175 for non-preferred brands in 2026. Confirm the medication, approved supply, and mail availability rather than treating those copays as a guaranteed Wegovy quote. MPDP members use a separate benefit. PSHB comparison · MPDP
Does FEP Blue cover Wegovy for heart health?
Wegovy has an FDA-approved cardiovascular-risk-reduction use for eligible adults. FEP's reviewed policy does not publish a separate cardiovascular-only checklist, though established cardiovascular disease can qualify under its adult weight-management criteria at BMI 27 or more. Ask which review applies to your exact diagnosis and benefit; do not read the missing checklist as an automatic denial. Label · FEP policy
The bottom line on FEP Blue GLP-1 coverage
Your FEP Blue option, pharmacy benefit, and reason for treatment decide the coverage path. Standard and Basic list Wegovy at Tier 3, Focus needs an exception for it, and Zepbound needs an exception on every option. Check your real price before you fill, keep the records FEP needs, and pay for extra help only when it solves a problem you actually have. FEP lists · Exception rules
